Research Paper Volume 5, Issue 7 pp 531—538
Platelet-derived growth factor B induces senescence and transformation in normal human fibroblasts
- 1 Inserm U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, F-69000, France
- 2 CNRS UMR5286, Lyon, F-69000, France
- 3 Centre Léon Bérard, Lyon, F-69000, France
- 4 Université de Lyon, Lyon, F-69000, France
- 5 Cell Death, Senescence, and Survival Group, Departament de Bioquimica i Biologia Molecular and Institut de Neurociencies, Facultat de Medicina, Universitat Autonoma de Barcelona, Barcelona, 08193, Spain
- 6 INSERM UMR-S940, Laboratoire de Pharmaco-Génétique AP-HP, Hôpital Saint-Louis, Paris, F-75000, France
- 7 Department of Dermatology AP-HP, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, F-75000, France
Received: May 3, 2013 Accepted: July 13, 2013 Published: July 15, 2013
https://doi.org/10.18632/aging.100577How to Cite
Abstract
Normal cells enter a senescent state upon aberrant oncogenic signals and this response inhibits tumor initiation and progression. It is now well admitted that intracellular and membrane localized oncogenes can illicit oncogene induced senescence. However, the effect of mitogenic growth factor on cellular senescence is so far largely unknown. Here we show that normal human dermal fibroblasts display a complex response to Platelet derived growth factor B (PDGFB) expression. Indeed, PDGFB expression induces, in the same cell population, both senescence and cellular transformation. Remarkably both populations are sustained with passages suggesting that transformed cells eventually enter a senescent state. This senescence state is p53 dependent as inhibiting the p53 pathway blocks the ability of PDGFB to induce senescence and results in strong cellular transformation increase upon PDGFB expression. The relevance of these observations is supported by the fact that human dermatofibrosarcoma protuberans, skin tumors arising from constitutive PDGFB production with little aggressiveness, also display some senescence hallmarks. Together these data support the view that PDGFB, a mitogenic growth factor, has a limited ability to induce senescence. We propose that this low level of senescence might decrease the transforming ability of this factor without totally abolishing it.